SCHEMBL5301151

SCHEMBL5301151

Cc1cc(-c2ccccc2)nn1-c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.58
SMN1; SMN2 Q16637 6/20 0.58
NPC1 O15118 6/20 0.58
ALDH1A1 P00352 5/20 0.58
MAPT P10636 3/20 0.58
STAT1 P42224 1/20 0.58
KDM4E B2RXH2 6/20 0.57
MAPK1 P28482 3/20 0.57
HSD17B10 Q99714 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
HPGD P15428 1/20 0.57
ALOX15 P16050 1/20 0.57
MCL1 Q07820 1/20 0.57
NFKB1 P19838 2/20 0.55
NFKB2 Q00653 2/20 0.55
RELA Q04206 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
TSHR P16473 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18134654 0.88 SMN1; SMN2 (0.56) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL6098171 0.84 SMN1; SMN2 (0.48) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL6096142 0.82 SMN1; SMN2 (0.46) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL12670655 0.80 ALDH1A1 (0.55) ALDH1A1MAPTKDM4EMAPK1HSD17B10
SCHEMBL6449791 0.79 LMNA (0.56) ALDH1A1MAPTKDM4EMAPK1HPGD
SCHEMBL23401834 0.78 ALDH1A1 (0.64) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL1198398 0.78 RAB9A (0.65) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL964125 0.78 MAPK1 (0.66) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL18134657 0.78 ALDH1A1 (0.59) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL19002413 0.78 LMNA (0.63) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO claimed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US claimed
EP-4249480-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Northwest A&F University (CN) 2023-09-27 EP disclosed
US-10008675-B2 Organic compound and organic electroluminescent element comprising same DOOSAN CORPORATION (KR) 2018-06-26 US disclosed
US-9525141-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2016-12-20 US disclosed
US-20160351825-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2016-12-01 US disclosed
US-20160295864-A1 ETHEREAL OXYGEN ATOM-CONTAINING PERFLUOROALKYL GROUP-SUBSTITUTED PYRAZOLE RING COMPOUND AND METHOD FOR ITS PRODUCTION ASAHI GLASS COMPANY, LIMITED (JP) 2016-10-13 US disclosed
US-20150325798-A1 ORGANIC LIGHT-EMITTING DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2015-11-12 US disclosed
US-20150236262-A1 ORGANIC LIGHT-EMITTING DEVICES SAMSUNG DISPLAY CO., LTD (KR) 2015-08-20 US disclosed
US-20150060796-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2015-03-05 US disclosed
US-20140374711-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2014-12-25 US disclosed
EP-1956022-B1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL CO (JP) 2012-07-25 EP disclosed
US-7993760-B2 Compound for use in organic electroluminescent device and organic electroluminescent device NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-08-09 US disclosed
US-7993760-B2 Compound for use in organic electroluminescent device and organic electroluminescent device NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-08-09 US disclosed
US-20110084258-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2011-04-14 US disclosed
WO-2011010844-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2011-01-27 WO disclosed
US-20090302742-A1 Compound for Use in Organic Electroluminescent Device and Organic Electroluminescent Device NIPPON STEEL CHEMICAL CO., LTD. (JP) 2009-12-10 US disclosed
EP-1956022-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT Nippon Steel Chemical Co., Ltd. (JP) 2008-08-13 EP disclosed
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090302742-A1 Compound for Use in Organic Electroluminescent Device and Organic Electroluminescent Device LAGE3, ICMT, PPOX RAB9A 2408/4885SMN1; SMN2 4361/4885NPC1 4722/4885
US-20160351825-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OR10J3, ORAI2, ETV6 RAB9A 2456/4885SMN1; SMN2 1538/4885NPC1 1548/4885
US-20160295864-A1 ETHEREAL OXYGEN ATOM-CONTAINING PERFLUOROALKYL GROUP-SUBSTITUTED PYRAZOLE RING COMPOUND AND METHOD FOR ITS PRODUCTION CYP2F1, CYP2E1, CYP2C19 RAB9A 1389/4885SMN1; SMN2 4279/4885NPC1 1285/4885
US-10008675-B2 Organic compound and organic electroluminescent element comprising same OR10J3, ORAI2, ETV6 RAB9A 2456/4885SMN1; SMN2 1538/4885NPC1 1548/4885
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 RAB9A 20/4885SMN1; SMN2 3894/4885NPC1 4197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.